How much funding has Berry Genomics raised?

Berry Genomics has raised $129.8M in total funding, most recently a Series B round.

Who are Berry Genomics's investors?

Berry Genomics's investors include Qiming VP, Legend Capital.

When was Berry Genomics founded?

Berry Genomics was founded in 2010.

Where is Berry Genomics headquartered?

Berry Genomics is headquartered in Beijing, China.

What industry is Berry Genomics in?

Berry Genomics operates in Healthcare, Genomics, Diagnostics.

How many employees does Berry Genomics have?

Berry Genomics has 201-500 employees.

Berry Genomics

IPO

Genomics from preconception to adulthood

Public · Beijing, China · Founded 2010 · $129.8M raised

Healthcare

Genomics

Diagnostics

Headquarters: Beijing
Employees: 201–500
Founded: 2010
Business Model: B2B
Website: berrygenomics.com

Total Funding: $129.8M
Last Round: $99.2M Series BJan 2020
Rounds: 3
Type: Public

About

Berry Genomics (北京贝瑞和康生物技术有限公司) was founded in May 2010 and is China's leading genomics company. Berry Genomics pioneered the first NGS-based non-invasive prenatal testing (NIPT) in China in 2010, and currently provides genetic test services to over 2,000 hospitals in China. In August 2017, Berry Genomics became the first genomic company to be listed on the main board of China A share exchange (stock code: 000710). The company also founded Berry Oncology in 2017, focusing on cancer early detection and liquid biopsy.

Summary

Berry Genomics is a Healthcare company based in Beijing, China, founded in 2010. It has raised $129.8M in total across 3 rounds, most recently a $99.2M Series B round in Jan 2020. Investors include Qiming VP and Legend Capital.